A reconstituted peptide has a shorter working life than the dry powder it came from, and how much shorter depends on which residues the sequence contains. Published storage guidance treats peptides as one category. The degradation chemistry does not, because the reactions that shorten a solution's life each need a specific residue to attack.

This article sets out what the published data supports about stability after reconstitution, then maps the degradation routes onto the structural classes that determine which route applies to which compound.

All Janera Science compounds are supplied strictly for in-vitro laboratory research use only. They are not for human or veterinary use and have not been evaluated by the FDA. Nothing here is guidance for use in humans or animals.

What Changes at the Moment of Reconstitution

Adding solvent restarts every degradation reaction that the dried state had suspended. Lyophilization removes the water that most degradation pathways require, which is why research peptides are supplied as dry powder. Reconstitution puts that water back.

Published work on peptide handling is direct about the consequence. Long-term storage of peptides beyond six months is most effective when they are lyophilized and held at -20 to -80 degrees Celsius, while working solutions are treated as short-term material with a window of three months or less (Clinical Chemistry, 2016).

That contrast is the useful frame. The dry vial is measured in years, the solution in weeks to months, and the gap between them is not a matter of degree. Our guide to lyophilization covers why the dried state is so much more durable.

The clock runs on chemistry

A solution does not expire on a date. It degrades through specific reactions running at rates set by temperature, pH, light exposure, oxygen availability, and the residues present in the sequence.

This is why a single shelf-life figure applied across a catalogue is a poor instrument. Two compounds reconstituted the same way on the same day can hold their purity for very different periods.

The Four Degradation Routes, and the Residues Each One Needs

Each major degradation route requires a particular amino acid to act on, so a sequence lacking that residue is not exposed to that route. This is the mechanism that makes stability a property of the individual compound.

Published analysis of peptide handling identifies the residue-specific vulnerabilities directly: cysteine, methionine, and tryptophan are prone to reversible and irreversible oxidation, and that conversion is accelerated during freeze-thaw cycles and at high pH; glutamine and asparagine are prone to deamidation; aspartic acid is sensitive to hydrolysis; and amino acids containing aromatic rings are susceptible to photochemical degradation (Clinical Chemistry, 2016).

Each of these produces a distinct analytical signature, which is what makes them identifiable rather than merely suspected. The mass shifts and chromatographic behaviour of each class are covered in our guide to synthesis impurities, and the same signatures appear whether the impurity formed during synthesis or during storage.

Why oxidation dominates the practical picture

Of the four routes, oxidation is the one most often observed in reconstituted material, because it needs only dissolved oxygen and time. It also has the clearest relationship to handling practice, since the same freeze-thaw cycling that laboratories are warned about is named as an accelerant.

The sulfur-containing residues are the ones that make a compound oxidation-exposed. That single fact does most of the sorting work in the table further down.

Reading the Sequence to Predict the Route

A molecular formula alone reveals whether the sulfur-based oxidation routes apply. Cysteine and methionine are the only two standard amino acids that carry sulfur, so a formula containing no sulfur atom cannot contain either residue.

This is a small piece of reasoning with a large practical payoff. It converts a published formula, which appears on any credible certificate of analysis, into a statement about which degradation chemistry a compound is exposed to.

Reading a formula and a sequence from documentation is covered in our guide to peptide nomenclature, and the identity fields that carry this information are set out in our guide to reading a certificate of analysis.

Mapping the Classes onto Real Compounds

The table below applies that reasoning to compounds in the Janera Science catalogue, using the molecular formulas and sequence positions published in our own compound articles.

Three points follow from the completed rows.

MOTS-c carries the heaviest exposure in the catalogue. Two methionines, a tryptophan, and two tyrosines place it in both the oxidation and the photodegradation classes at once, which is why its solutions warrant the most conservative handling and the most protection from light.

Semax has a single, locatable vulnerability. One methionine at the N-terminus means one oxidation site, and a plus 16 dalton signal on a mass spectrum points directly at it.

Selank and BPC-157 are not immune, they are differently exposed. Neither formula contains sulfur, so the methionine and cysteine routes are unavailable. Hydrolysis and deamidation still apply wherever the relevant residues sit in the chain, so the correct read is a different risk profile rather than a longer guarantee.

Temperature, and What the Measured Data Actually Showed

Colder storage slows every route, which is why the published guidance converges on frozen storage for anything held beyond immediate use. Peptides held for more than six months are best kept lyophilized at -20 to -80 degrees Celsius, and solutions are treated as short-term material (Clinical Chemistry, 2016).

The freeze-thaw question deserves a more careful answer than it usually receives. The standard advice is that multiple freeze-thaw cycles should be avoided, and that advice is sound as a default. The same published work notes it directly.

What is worth reporting alongside it is what the measurement showed. In that study's own comparison, samples held at 4 degrees Celsius, samples subjected to a single freeze-thaw, and samples put through ten freeze-thaw cycles produced comparable peak areas, with no significant difference between those conditions (Clinical Chemistry, 2016).

That result does not overturn the guidance. It was one peptide under one set of conditions, and the oxidation-prone residues are separately identified as being accelerated by freeze-thaw cycling. It does mean the blanket warning is a precaution rather than a measured universal, and a laboratory that aliquots is buying certainty rather than correcting a demonstrated loss.

Why aliquoting is still the right default

Aliquoting removes the variable entirely, at essentially no cost. Dividing material into single-use portions before the first freeze means no portion is ever cycled, and it limits how often the bulk is opened to the air, which addresses the oxidation route at the same time.

For an oxidation-exposed compound such as MOTS-c, that second benefit matters as much as the first. Our guide to peptide storage and stability covers the temperature targets and handling practice in full.

The temperature bands quoted in circulation

Precise hour-by-hour and week-by-week figures circulate widely for reconstituted peptides, and most of them are not traceable to a published measurement. Guides commonly assert that solutions hold for a set number of hours at room temperature, a set number of weeks refrigerated, and a set number of months frozen, stated without a source.

What the published handling literature actually supports is coarser and more defensible: lyophilized material held beyond six months belongs at -20 to -80 degrees Celsius, and solutions are treated as short-term material with a window of three months or less (Clinical Chemistry, 2016).

The distinction matters for anyone planning work around a stated figure. A number with a measurement behind it can be relied on. A number that circulates because it has been repeated tells you what convention has settled on, which is a weaker thing, and it will differ by compound in any case because the residue exposure differs.

The practical position that follows is to treat any single quoted shelf life as a planning convention rather than a property of the material, and to anchor real decisions to two things instead: colder is slower, and the specific residues in the sequence decide which reaction is running.

Solvent and pH move the rate as much as temperature does

The solvent a peptide sits in is not a neutral background, because it sets the pH, and pH drives one of the four routes directly. Oxidation of cysteine, methionine and tryptophan is accelerated at high pH (Clinical Chemistry, 2016), so a solution held under alkaline conditions is running its oxidation clock faster than the same peptide held nearer neutral.

That places solvent selection inside the stability question rather than beside it. A solvent chosen only for how readily it dissolves the powder may be holding the peptide at a pH that shortens its working life, and for an oxidation-exposed sequence that trade is a poor one.

Dissolved oxygen is the second solvent-side variable. Because the oxidation routes need oxygen, minimizing headspace and air exposure at the point of reconstitution and at every subsequent opening reduces the supply the reaction depends on.

Solvent selection by peptide class, and the handling sequence around it, are covered in our guide to peptide storage and stability.

Confirming Degradation Rather Than Assuming It

A solution that has degraded does not reliably look different, so visual inspection is not a test. Cloudiness or visible particulate is a signal worth acting on, but its absence proves nothing, because the oxidation and deamidation products that shorten a peptide's useful life stay in solution and stay invisible.

What confirms the state of the material is the same pair of analytical methods that established its purity at the outset. High-performance liquid chromatography separates the degradation products from the intact peptide and quantifies the split, and mass spectrometry identifies what those products are from their mass shifts.

An oxidized methionine appears as a plus 16 dalton species. A deamidated residue appears as a plus 0.984 dalton shift that needs a high-resolution instrument to resolve. These methods are covered in our guide to purity testing.

The practical consequence is that stability is only measurable against a documented starting point. A certificate of analysis recording identity and purity at release is what a later measurement is compared to, and without it there is no baseline to detect drift against. Janera Science publishes third-party documentation for every batch supplied, available on our lab results page.

Frequently Asked Questions

How long does a reconstituted peptide remain usable?

Published handling guidance treats solutions as short-term material with a working window of three months or less, against lyophilized storage that runs for years at -20 to -80 degrees Celsius (Clinical Chemistry, 2016). The specific window depends on temperature, light exposure, and which degradation-prone residues the sequence contains.

Why do two peptides stored identically degrade at different rates?

Because each degradation route requires a particular residue. A sequence containing methionine or cysteine is exposed to oxidation, one containing asparagine or glutamine is exposed to deamidation, and a sequence lacking those residues is not exposed to those specific routes at all.

Can a molecular formula tell me anything about stability?

Yes, in one specific way. Cysteine and methionine are the only standard amino acids containing sulfur, so a formula with no sulfur atom cannot contain either, which rules out the sulfur-based oxidation routes for that compound.

Do freeze-thaw cycles definitely damage peptides?

The standard guidance is to avoid multiple cycles, and freeze-thaw is separately identified as accelerating oxidation of cysteine, methionine and tryptophan. In one published comparison, however, samples at 4 degrees Celsius, at one freeze-thaw, and at ten freeze-thaw cycles showed comparable peak areas with no significant difference (Clinical Chemistry, 2016). Aliquoting removes the question at negligible cost.

Which compounds need the most protection from light?

Those containing aromatic residues, since tryptophan, tyrosine and phenylalanine are susceptible to photochemical degradation. MOTS-c, with a tryptophan and two tyrosines alongside two methionines, sits in both the photodegradation and oxidation classes.

Can I tell by looking whether a solution has gone off?

No. Visible cloudiness or particulate is worth acting on, but most degradation products remain dissolved and invisible. Confirmation requires chromatography and mass spectrometry compared against the documented purity at release.

Key Takeaways

• Reconstitution restarts the reactions that the dried state suspended. Lyophilized material stored at -20 to -80 degrees Celsius is measured in years, and solutions are treated as short-term material of three months or less (Clinical Chemistry, 2016).

• Each degradation route needs a specific residue. Oxidation requires cysteine, methionine or tryptophan; deamidation requires asparagine or glutamine; photodegradation requires an aromatic residue.

• A molecular formula containing no sulfur rules out the cysteine and methionine oxidation routes, which makes the formula on a certificate of analysis a usable stability signal.

• Within the Janera Science catalogue, MOTS-c carries the heaviest exposure with two methionines, a tryptophan and two tyrosines, while Selank and BPC-157 carry no sulfur at all.

• Degradation is confirmed analytically, against a documented release baseline. Visual inspection does not confirm it.

All Janera Science compounds are supplied strictly for in-vitro laboratory research use only. They are not for human or veterinary use and have not been evaluated by the FDA.